Advances in Psychedelic Medicine

State-of-the-Art Therapeutic Applications
Herausgeber: Sessa, Ben; Winkelman, Michael

• Gebundenes Buch

Produktbeschreibung

Researchers, program administrators, and practicing clinicians explain the most recent developments in using psychedelic substances to treat psychological, physiological, and social problems. More than a decade ago, the U.S. government lifted its ban on all testing of psychedelic substances. Winkelman and Sessa now provide updated scientific research and applications of these substances, now moving into approved categories of medicine. The text is an up-to-date assessment of the latest advances in the field of psychedelic medicine, covering the use of LSD, psilocybin, MDMA, ayahuasca, and other substances to augment psychotherapies for a range of disorders. It discusses medical and psychiatric concerns, clinical efficacy and safety, ethical considerations, and neuroscience findings regarding the psychedelic compounds. Topics covered include an overview of psychiatric applications of psychedelics; treatments for addictions and depressive disorders; effects of psychedelics on inflammation and neuroplasticity; evidence for clinical applications of DMT, ayahuasca, and cannabidiol; psychedelic treatment of sociopathic disorders; microdosing psychedelics; training psychedelic therapists; and community-based harm reduction approaches to managing psychedelic crises.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Praeger
• Seitenzahl: 400
• Erscheinungstermin: 31. März 2019
• Englisch
• Abmessung: 240mm x 161mm x 26mm
• Gewicht: 763g
• ISBN-13: 9781440864100
• ISBN-10: 1440864101
• Artikelnr.: 54802730

Autorenporträt

Michael Winkelman, PhD, is retired from the School of Human Evolution and Social Change at Arizona State University, where he served as director of the medical anthropology program. Ben Sessa, MD, is a consultant child and adolescent psychiatrist working in adult addiction services and with PTSD in veterans.

Inhaltsangabe

Acknowledgments Chapter 1 Introduction: The Psychedelic Renaissance
Continues Michael Winkelman and Ben Sessa Part One Psychiatry Chapter 2
Psychedelics and Psychiatry: A New Treatment Model for the 21st Century
Charles S. Grob and Gary Bravo Chapter 3 Therapeutic Applications of
3,4-methylenedioxymethamphetamine (MDMA) Ben Sessa Chapter 4 Psilocybin
Therapy for Major Depressive Disorder James JH Rucker Chapter 5 Ketamine
Therapy for Treatment-Resistant Depression L. Alison McInnes and Marc
Ettensohn Chapter 6 Evidence for the Therapeutic Effects of Ayahuasca
Dráulio Barros de Araújo Part Two Substance Abuse Chapter 7 Psilocybin for
the Treatment of Substance Use Disorders Ishani Rao and Greg Lydall
Chapter 8 Potential Applications of Cannabis and Cannabinoids in the
Treatment of Substance Use Disorder and in Harm Reduction José Carlos
Bouso, Rafael Guimaraes dos Santos, and Jaime Hallak Chapter 9 Psychedelic
Therapy as a Complementary Treatment Approach for Alcohol Use Disorders
Peter Eischens and William Leigh Atherton Part Three Medical Hypotheses
Chapter 10 Effects of Psychedelics on Inflammation and Immunity Attila
Szabo Chapter 11 The Protective Role of Dimethyltryptamine against
Ischemia-Reperfusion Injury Ede Frecska, Attila Istvan Kovacs, and Attila
Szabo Chapter 12 Psychedelic Treatment of Disruptive Personality Patterns
Petr Winkler and Rita Kocárová Part Four Treatment and Training Chapter 13
Guidelines in Applying Psychedelic Therapies Friederike Meckel Chapter 14
Training Psychedelic Therapists Janis Phelps Part Five Societal Engagement
with Psychedelics Chapter 15 Community-Based Full-Spectrum Harm Reduction
Approaches When Caring for Psychoactive- and Psychedelic-Related Problems
at a Transformational Festival Maria Carmo Carvalho, Cristiana Vale Pires,
Ana Luísa Costa, Daniel Martins, Helena Valente, Inês Macedo, Paula Frango,
and Raquel Lira Chapter 16 Microdosing Psychedelics James Fadiman and
Sophia Korb Chapter 17 Bringing Psychedelics and Entactogens into
Mainstream Pharmaceuticals: A Focus on MDMA Anne C. Wagner, Michael C.
Mithoefer, and Rick Doblin About the Editors and Contributors Index